CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 144 Insider Sale of Securities
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes CLO & Secretary gave up 1,325 shares (to pay taxes)
- 8-K Event Material agreement · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Director sold 467 shares at $131.88 ($61,586)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 934 shares at $125.00 ($116,750)
- 144 Insider Sale of Securities
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Conversion 10% owner acquired 1,500,000 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition CLO & Secretary acquired 233 shares (other)
- 4 Other acquisition Chief Financial Officer acquired 224 shares (other)
- 4 Other acquisition Chief Executive Officer acquired 233 shares (other)
- 3/A Insider 3/A
- 8-K Event Regulation FD disclosure
- 4 Open-market sale CLO & Secretary sold 500 shares at $114.08 ($57,042)
Page 8 of 115 · 2,300 filings